Balentine LLC’s Affirm AFRM Stock Holding History

Balentine LLC’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,348	Closed	-$214K	–	593
2023 Q4	$214K	Buy	+4,348	New	+$126K	0.01%	473
2023 Q1	–	Sell	-23,953	Closed	-$232K	–	604
2022 Q4	$232K	Buy	+23,953	New	+$361K	0.01%	500

Other funds holding AFRM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Balentine LLC's AFRM Position: Q1 2024 in Review

Balentine LLC sold out of Affirm (AFRM) in Q1 2024, closing a stake of 4,348 shares — an estimated $214K sold.

Balentine LLC first reported a position in AFRM in Q4 2022 and held it in 2 quarters. The position peaked at $232K in Q4 2022. 384 funds tracked by Wall St. Rank hold AFRM as of Q1 2024.

Balentine LLC reported no remaining Affirm position as of Q1 2024 after selling out during the quarter.
Balentine LLC sold 4,348 Affirm shares in Q1 2024, an estimated $214K.
Balentine LLC first reported a position in Affirm in Q4 2022 and held it in 2 quarters.
Balentine LLC's Affirm position peaked at $232K in Q4 2022.
384 funds tracked by Wall St. Rank held Affirm as of Q1 2024.

Based on Balentine LLC's 13F filing for Q1 2024, filed 15 May 2024.